MEDIUMOutside partyCustomer
technology industry clients
“10-K Item 1A: 'In addition, we generate a significant portion of our revenue from clients in the technology industry.'”
PGNY · Concentration risk · 10-K extracted
Progyny (PGNY) concentration risks
Updated
The most significant concentration Progyny discloses is technology industry clients, classified MEDIUM by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Source: Progyny’s SEC Form 10-K filed — view the filing on SEC EDGAR ↗
At a glance
Disclosed-size breakdown · 1 disclosed concentration
HIGH0
MEDIUM1
LOW0
Disclosed concentrations
Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).
TrendMatrix Research · concentration synthesis
What these concentrations mean together
updated 2026-07-06Progyny's disclosed concentration is narrower than many peers: the company states that it generates a significant portion of its revenue from clients in the technology industry. No percentage, specific client name, or geographic breakdown accompanies this disclosure, so the exposure should be read as a client-industry dependency rather than a structural feature of the business model itself — Progyny's fertility-benefits offering is not inherently tied to any one industry, but its current client base happens to skew toward technology employers. That makes the exposure somewhat idiosyncratic: a hiring slowdown, layoffs, or benefits-budget cuts concentrated in the technology sector could disproportionately affect Progyny's revenue relative to a company with a more industry-diversified client base. Because the filing does not quantify "significant" with a percentage, the practical size of the exposure is harder to pin down than customer-percentage or loan-concentration disclosures typical of other names, but the company's own framing signals this is a real dependency worth tracking, not a boilerplate risk factor. On balance, this reads as a single, moderate-share exposure rather than one large enough to dominate the overall risk picture on its own.
For the engine’s reasoning on PGNY’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.
Industry peers · Healthcare Plans
Peer concentration profile
| Symbol | Name | HIGH | MEDIUM | LOW | Total |
|---|---|---|---|---|---|
| ALHC | Alignment Healthcare, Inc. | 1 | 1 | 0 | 2 |
| CNC | Centene Corporation | 1 | 0 | 2 | 3 |
| CI | The Cigna Group | 0 | 5 | 0 | 5 |
| PGNY● | Progyny, Inc. | 0 | 1 | 0 | 1 |
| CVS | CVS Health Corporation | 0 | 0 | 1 | 1 |
| CLOV | Clover Health Investments, Corp | 0 | 0 | 0 | 0 |
Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.